Most read article(s)

Article
Lipoic acid in secondary progressive MSA randomized controlled pilot trial
Rebecca Spain, Katherine Powers, Charles Murchison, et al.

June 28, 2017
Article
New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD
Yukio Takeshita, Susumu Fujikawa, Kenichi Serizawa, et al.

October 19, 2021
Article
Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis
John C. Probasco, Lilja Solnes, Abhinav Nalluri, et al.

May 11, 2017
Research Article
Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
Huah Shin Ng, Feng Zhu, Elaine Kingwell, et al.

June 14, 2022
Views & Reviews
IgG4-Mediated Neurologic AutoimmunitiesUnderstanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
Marinos C. Dalakas

November 29, 2021
Research Article
Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies
Michael Winklehner, Jan Bauer, Verena Endmayr, et al.

July 07, 2022
Views & Reviews
Autoimmune NeurologyThe Need for Comprehensive Care
Justin R. Abbatemarco, Stefanie J. Rodenbeck, Gregory S. Day, et al.

June 15, 2021
Article
Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-MAG NeuropathyRetrospective Study
Pascal Hänggi, Butrint Aliu, Kea Martin, et al.

November 10, 2021
Research Article
Updated Results of the COVID-19 in MS Global Data Sharing InitiativeAnti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, et al.

August 29, 2022
Article
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, et al.

January 16, 2017

Pages